Accuron Technologies plans to further develop its suite of medical devices outsourcing services through its recent acquisition of a majority stake in Aurum Healthcare, a provider of sterilisation services for medical devices and instruments.

"Nantong Jinghua Pharma will become a 78.3% stakeholder in Jiangsu Kingsley Pharmaceuticals."

According to the agreement, Accuron Technologies will place Aurum Healthcare under its Advanced Materials Technologies (AMT) business in order to increase AMT’s manufacturing footprint.

Nantong Jinghua Pharma, a Chinese traditional pharma products manufacturer, plans to acquire an additional 29.73% stake in Jiangsu Kingsley Pharmaceuticals.

Following the transaction, Nantong Jinghua Pharma will become a 78.3% stakeholder in Jiangsu Kingsley Pharmaceuticals.